1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Congenital lobar emphysema: new trials by email Literature Review of Congenital lobar emphysema trials Research Report on Congenital lobar emphysema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE) Alpha1-Proteinase Inhibitor (Human), Albumin (Human) 20%, United States Pharmacopeia (USP) - Alpha 1-Antitrypsin Deficiency | Phase 2 | Completed | Grifols Therapeutics LLC | 77 | 2003-12-01 | 2014-08-21 |
alpha 1-Antitrypsin Deficiency (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Emphysema (1) · Genetic Diseases, Inborn (1) · Liver Diseases (1) · Lung Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Subcutaneous Emphysema (1)
Albumins (1) · alpha 1-Antitrypsin (1)
Denmark (1) · Sweden (1) · United Kingdom (1)
PMID 19196813, PMID 19251783, PMID 19483042, PMID 19678952, PMID 20920370, PMID 21617168, PMID 23226015